HRP20200385T1 - 6-kloro-3-(fenil-d5)-inden-1-on i njegove uporabe - Google Patents
6-kloro-3-(fenil-d5)-inden-1-on i njegove uporabe Download PDFInfo
- Publication number
- HRP20200385T1 HRP20200385T1 HRP20200385TT HRP20200385T HRP20200385T1 HR P20200385 T1 HRP20200385 T1 HR P20200385T1 HR P20200385T T HRP20200385T T HR P20200385TT HR P20200385 T HRP20200385 T HR P20200385T HR P20200385 T1 HRP20200385 T1 HR P20200385T1
- Authority
- HR
- Croatia
- Prior art keywords
- phenyl
- chloro
- indan
- compound
- indane
- Prior art date
Links
- VBFPHOYPKVNWMJ-RALIUCGRSA-N 6-chloro-3-(2,3,4,5,6-pentadeuteriophenyl)inden-1-one Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1C1=CC(=O)C2=CC(Cl)=CC=C12 VBFPHOYPKVNWMJ-RALIUCGRSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 18
- 238000000034 method Methods 0.000 claims 18
- MZYSFGBQMMGPIL-UXQPRIDPSA-N (1s,3s)-3,5-dichloro-1-(2,3,4,5,6-pentadeuteriophenyl)-2,3-dihydro-1h-indene Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[C@H]1C2=CC=C(Cl)C=C2[C@@H](Cl)C1 MZYSFGBQMMGPIL-UXQPRIDPSA-N 0.000 claims 7
- MZYSFGBQMMGPIL-RALIUCGRSA-N 3,5-dichloro-1-(2,3,4,5,6-pentadeuteriophenyl)-2,3-dihydro-1h-indene Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1C1C2=CC=C(Cl)C=C2C(Cl)C1 MZYSFGBQMMGPIL-RALIUCGRSA-N 0.000 claims 7
- RGAOXVRFQQHTQY-RALIUCGRSA-N 6-chloro-3-(2,3,4,5,6-pentadeuteriophenyl)-2,3-dihydroinden-1-one Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1C1C2=CC=C(Cl)C=C2C(=O)C1 RGAOXVRFQQHTQY-RALIUCGRSA-N 0.000 claims 7
- 238000006243 chemical reaction Methods 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- FBCSWIXKXHSYBN-LSQWYULJSA-N 1-[(1r,3s)-6-chloro-3-(2,3,4,5,6-pentadeuteriophenyl)-2,3-dihydro-1h-inden-1-yl]-3,3-dimethylpiperazine Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[C@H]1C2=CC=C(Cl)C=C2[C@H](N2CC(C)(C)NCC2)C1 FBCSWIXKXHSYBN-LSQWYULJSA-N 0.000 claims 6
- NAJAIAYBHZAKNQ-RALIUCGRSA-N 6-chloro-3-(2,3,4,5,6-pentadeuteriophenyl)-1H-indene Chemical compound ClC1=CC=C2C(=CCC2=C1)C1=C(C(=C(C(=C1[2H])[2H])[2H])[2H])[2H] NAJAIAYBHZAKNQ-RALIUCGRSA-N 0.000 claims 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 6
- RGAOXVRFQQHTQY-URRYIOODSA-N (3s)-6-chloro-3-(2,3,4,5,6-pentadeuteriophenyl)-2,3-dihydroinden-1-one Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[C@H]1C2=CC=C(Cl)C=C2C(=O)C1 RGAOXVRFQQHTQY-URRYIOODSA-N 0.000 claims 5
- IJAZFUPBJOINDB-KPSZHSGHSA-N (1s)-6-chloro-3-(2,3,4,5,6-pentadeuteriophenyl)-1h-inden-1-ol Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1C1=C[C@H](O)C2=CC(Cl)=CC=C12 IJAZFUPBJOINDB-KPSZHSGHSA-N 0.000 claims 3
- FBCSWIXKXHSYBN-DKFMXDSJSA-N 1-[6-chloro-3-(2,3,4,5,6-pentadeuteriophenyl)-2,3-dihydro-1h-inden-1-yl]-3,3-dimethylpiperazine Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1C1C2=CC=C(Cl)C=C2C(N2CC(C)(C)NCC2)C1 FBCSWIXKXHSYBN-DKFMXDSJSA-N 0.000 claims 3
- ANNOOGSNJGTWOR-UHFFFAOYSA-N 3-bromo-6-chloroinden-1-one Chemical compound ClC1=CC=C2C(Br)=CC(=O)C2=C1 ANNOOGSNJGTWOR-UHFFFAOYSA-N 0.000 claims 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 230000015572 biosynthetic process Effects 0.000 claims 3
- 239000003054 catalyst Substances 0.000 claims 3
- 238000007248 oxidative elimination reaction Methods 0.000 claims 3
- 238000001556 precipitation Methods 0.000 claims 3
- PIPWSBOFSUJCCO-UHFFFAOYSA-N 2,2-dimethylpiperazine Chemical compound CC1(C)CNCCN1 PIPWSBOFSUJCCO-UHFFFAOYSA-N 0.000 claims 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims 2
- MEDSHTHCZIOVPU-UHFFFAOYSA-N 5-chloro-2,3-dihydroinden-1-one Chemical compound ClC1=CC=C2C(=O)CCC2=C1 MEDSHTHCZIOVPU-UHFFFAOYSA-N 0.000 claims 2
- NVZAYUDBSXWJKD-RALIUCGRSA-N 6-chloro-3-(2,3,4,5,6-pentadeuteriophenyl)-2,3-dihydro-1h-inden-1-ol Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1C1C2=CC=C(Cl)C=C2C(O)C1 NVZAYUDBSXWJKD-RALIUCGRSA-N 0.000 claims 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 2
- 239000003638 chemical reducing agent Substances 0.000 claims 2
- 230000018044 dehydration Effects 0.000 claims 2
- 238000006297 dehydration reaction Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- -1 methyl-d3 Chemical class 0.000 claims 2
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 claims 2
- 230000008707 rearrangement Effects 0.000 claims 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 238000003786 synthesis reaction Methods 0.000 claims 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims 2
- NVZAYUDBSXWJKD-AQLFGSDDSA-N (1R,3R)-6-chloro-3-(2,3,4,5,6-pentadeuteriophenyl)-2,3-dihydro-1H-inden-1-ol Chemical compound ClC1=CC=C2[C@H](C[C@H](C2=C1)O)C1=C(C(=C(C(=C1[2H])[2H])[2H])[2H])[2H] NVZAYUDBSXWJKD-AQLFGSDDSA-N 0.000 claims 1
- NVZAYUDBSXWJKD-UXQPRIDPSA-N (1s,3s)-6-chloro-3-(2,3,4,5,6-pentadeuteriophenyl)-2,3-dihydro-1h-inden-1-ol Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[C@H]1C2=CC=C(Cl)C=C2[C@@H](O)C1 NVZAYUDBSXWJKD-UXQPRIDPSA-N 0.000 claims 1
- JHWIEAWILPSRMU-UHFFFAOYSA-N 2-methyl-3-pyrimidin-4-ylpropanoic acid Chemical compound OC(=O)C(C)CC1=CC=NC=N1 JHWIEAWILPSRMU-UHFFFAOYSA-N 0.000 claims 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims 1
- SMSGJDOJSQHQIW-UHFFFAOYSA-N 6-chloro-2,3-dihydroinden-1-one Chemical compound ClC1=CC=C2CCC(=O)C2=C1 SMSGJDOJSQHQIW-UHFFFAOYSA-N 0.000 claims 1
- IJAZFUPBJOINDB-RALIUCGRSA-N 6-chloro-3-(2,3,4,5,6-pentadeuteriophenyl)-1h-inden-1-ol Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1C1=CC(O)C2=CC(Cl)=CC=C12 IJAZFUPBJOINDB-RALIUCGRSA-N 0.000 claims 1
- 238000003747 Grignard reaction Methods 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims 1
- 230000029936 alkylation Effects 0.000 claims 1
- 238000005804 alkylation reaction Methods 0.000 claims 1
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000005660 chlorination reaction Methods 0.000 claims 1
- 150000002081 enamines Chemical class 0.000 claims 1
- 239000011982 enantioselective catalyst Substances 0.000 claims 1
- 238000005984 hydrogenation reaction Methods 0.000 claims 1
- YIAPLDFPUUJILH-UHFFFAOYSA-N indan-1-ol Chemical compound C1=CC=C2C(O)CCC2=C1 YIAPLDFPUUJILH-UHFFFAOYSA-N 0.000 claims 1
- 150000002468 indanes Chemical class 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- QDKJWXBGYXJIOS-UHFFFAOYSA-N n-(dimethoxymethyl)-n-ethylethanamine Chemical compound CCN(CC)C(OC)OC QDKJWXBGYXJIOS-UHFFFAOYSA-N 0.000 claims 1
- 239000012038 nucleophile Substances 0.000 claims 1
- 125000002524 organometallic group Chemical group 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims 1
- FJVZDOGVDJCCCR-UHFFFAOYSA-M potassium periodate Chemical compound [K+].[O-]I(=O)(=O)=O FJVZDOGVDJCCCR-UHFFFAOYSA-M 0.000 claims 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims 1
- 150000003283 rhodium Chemical class 0.000 claims 1
- QBERHIJABFXGRZ-UHFFFAOYSA-M rhodium;triphenylphosphane;chloride Chemical compound [Cl-].[Rh].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QBERHIJABFXGRZ-UHFFFAOYSA-M 0.000 claims 1
- 239000012279 sodium borohydride Substances 0.000 claims 1
- 229910000033 sodium borohydride Inorganic materials 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- INQOMBQAUSQDDS-FIBGUPNXSA-N trideuterio(iodo)methane Chemical compound [2H]C([2H])([2H])I INQOMBQAUSQDDS-FIBGUPNXSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
- C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (14)
1. Postupak za proizvodnju spoja (I)
[image]
pri čemu je spoj (I) dobiven reakcijom 3-bromo-6-kloro-inden-1-ona s 4,4,5,5-tetrametil-2-d5-fenil-[1,3,2]dioksaborolanom.
2. Postupak prema zahtjevu 1 koji sadrži sljedeće korake
a) 2,2'-azo-bis-izobutironitril i N-bromosukcinimid se dodaju u otopinu koja sadrži 6-kloro-1-indanon
b) trietilamin se dodaje u otopinu prema koraku a) kako bi se dobio 3-bromo-6-kloro-inden-1-on
c) 3-bromo-6-kloro-inden-1-on se razdvaja i reagira s 4,4,5,5-tetrametil-2-d5-fenil-[1,3,2]dioksaborolanom u prisutnosti prigodnog katalizatora i baze kako bi se dobio spoj (I).
3. Postupak prema zahtjevu 2, pri čemu se korak c) izvodi u prisutnosti paladij acetata i trifenilfosfina.
4. Postupak za proizvodnju spoja (I)
[image]
koji sadrži korake
a) Sinteza 6-kloro-3-(fenil-d5)-1H-indena (IV) reakcijom između organometalnih vrsta dobivenih od monohalogeniziranog benzena-ds i 5-kloro-1-indanona (V) nakon čega slijedi dehidracija.
b) Reagiranje 6-kloro-3-(fenil-d5)-1H-indena (IV) na spoj (E)-1-(6-kloro-3-fenil(d5)-1H-inden-1-ilidenmetil)-N,N-dimetilamin (XIX) i njegovo daljnje oksidativno cijepanje kako bi se dobio spoj (I).
5. Postupak prema zahtjevu 4 koji sadrži korake
a) Sinteza 6-kloro-3-(fenil-d5)-1H-indena (IV) Grignard reakcijom između bromobenzena-ds, magnezija i 5-kloro-1-indanona nakon čega slijedi dehidracija.
b) Reagiranje 6-kloro-3-(fenil-d5)-1H-indena prema koraku a) s 1,1-dimetoksi-N,N-dietilmetanaminom nakon čega slijedi oksidativno cijepanje oblikovanog enaminskog intermedijera (XIX) kako bi se dobio spoj (I).
6. Postupak prema zahtjevu 4 ili 5, pri čemu se oksidativno cijepanje u koraku b) izvodi korištenjem oksidativnog agensa odabranog od skupine koja se sastoji od natrij metaperjodata, kalij metaperjodata, ozona, kalij dikromata, natrij dikromata, atomarnog kisika i m-kloroperbenzojeve kiseline.
7. Postupak prema bilo kojem od zahtjeva 1 ili 4 koji dalje sadrži korake
a) Spoj (I) se reducira kako bi se dobio 6-kloro-3-(fenil-d5)-1H-inden-1-ol (VIa).
b) Spoj (VIa) se konvertira u 6-kloro-3-(fenil-d5)-indan-1-on (VIIIa) putem preraspodjele inducirane bazom.
8. Postupak prema bilo kojem od zahtjeva 1 ili 4 koji dalje sadrži korake
a) Spoj (I) se konvertira u (S)-6-kloro-3-(fenil-d5)-1H-inden-1-ol (VII) putem enantioselektivne redukcije u prisutnosti enantioselektivnog katalizatora i redukcijskog sredstva.
b) Spoj (VII) se konvertira u (S)-6-kloro-3-(fenil-d5)-indan-1-on (IX) putem preraspodjele inducirane bazom.
9. Postupak prema bilo kojem od zahtjeva 1 ili 4 koji dalje sadrži konverziju Spoja (I) kako bi se dobio 6-kloro-3-(fenil-d5)-indan-1-on (VIIIa) putem hidrogenacije u prisutnosti prikladnog katalizatora, poput tris(trifenil-fosfin)rodij(I) klorida, u prikladnom otapalu, poput etil acetata.
10. Postupak prema bilo kojem od zahtjeva 1 ili 4 koji dalje sadrži konverziju Spoja (I) kako bi se dobio (S)-6-kloro-3-(fenil-d5)-indan-1-on (IX) putem asimetrične hidrogenacije u prisutnosti prikladnog katalizatora, poput soli rodija, i liganda kiralnog fosfina i prikladnog otapala, poput etil acetata.
11. Postupak prema bilo kojem od zahtjeva 7 do 10, pri čemu su spojevi dobiveni u bilo kojem od zahtjeva 7 do 10 konvertirani u 3,5-dikloro-1-(fenil-d5)-indan, posebno (±)-cis-3,5-dikloro-1-(fenil-d5)-indan ili (1S,3S)-3,5-dikloro-1-(fenil-d5)-indan, postupak sadrži sljedeće korake
a) Reduciranje (±)-6-kloro-3-(fenil-d5)-indan-1-ona (VIII), 6-kloro-3-(fenil-d5)-indan-1-ona (VIIIa) ili (S)-6-kloro-3-(fenil-d5)-indan-1-ona (IX) kako bi se dobio odgovarajući indanol:
(±)-cis-6-kloro-3-(fenil-d5)-indan-1-ol (X), 6-kloro-3-(fenil-d5)-indan-1-ol (Xb) ili (1S,3S)-6-kloro-3-(fenil-d5)-indan-1-ol (Xa) u prisutnosti prikladnog redukcijskog sredstva, poput NaBH4;
b) Klorinacija, npr. u prisutnosti tionil klorida, bilo kojeg od spojeva dobivenih u koraku a) kako bi se dobio odgovarajući klorinirani spoj indana (±)-cis-3,5-dikloro-1-(fenil-d5)-indan (XI), 3,5-dikloro-1-(fenil-d5)-indan (XIb) ili (1S,3S)-3,5-dikloro-1-(fenil-d5)-indan (XIa).
12. Postupak prema zahtjevu 11, pri čemu se (±)-cis-3,5-dikloro-1-(fenil-d5)-indan (XI), 3,5-dikloro-1-(fenil-d5)-indan (XIb) ili (1S,3S)-3,5-dikloro-1-(fenil-d5)-indan (XIa) kako su dobiveni u zahtjevu 11 konvertiraju u farmaceutski prihvatljivu sol (±)-trans-1-(6-kloro-3-(fenil-d5)-indan-1-il)-3,3-dimetil-piperazina, 1-(6-kloro-3-(fenil-d5)-indan-1-il)-3,3-dimetil-piperazina ili 1-((1R, 3S)-6-kloro-3-(fenil-d5)-indan-1-il)-3,3-dimetilpiperazina, postupak sadrži sljedeće korake
a) reakcija s 2,2-dimetilpiperazinom ili spojem koji se naknadno može preoblikovati u 3,3-dimetilpiperazin dio (±)-trans-1-(6-kloro-3-(fenil-d5)-indan-1-il)-3,3-dimetil-piperazina, 1-(6-kloro3-(fenil-d5)-indan-1-il)-3,3-dimetil-piperazina ili 1-((1R, 3S)-6-kloro-3-(fenil-d5)-indan-1-il)-3,3-dimetilpiperazina;
b) stvaranje i izborno precipitacija farmaceutski prihvatljive soli dodavanjem odgovarajuće kiseline.
13. Postupak prema zahtjevu 12, pri čemu se farmaceutski prihvatljiva sol (±)-trans-1-(6-kloro-3-(fenil-d5)-indan-1-il)-3,3-dimetil-piperazina, 1-(6-kloro3-(fenil-d5)-indan-1-il)-3,3-dimetil-piperazina ili 1-((1R,3S)-6-kloro-3-(fenil-d5)-indan-1-il)-3,3-dimetilpiperazina dobivena u zahtjevu 12 konvertira u farmaceutski prihvatljivu sol 4-((1R,3S)-6-kloro-3-(fenil-d5)-indan-1-il)-1(d3),2,2-trimetil-piperazina, postupak sadrži sljedeće korake
a) alkilacija u prisutnosti aktivnog metil-d3 donora, poput metiljodida-d3, i baze, poput kalij hidroksida, i
b) precipitacija farmaceutski prihvatljive soli dodavanjem odgovarajuće kiseline.
14. Postupak prema zahtjevu 11, pri čemu je 3,5-dikloro-1-(fenil-d5)-indan, posebno (±)-cis-3,5-dikloro-1-(fenil-d5)-indan ili (1S,3S)-3,5-dikloro-1-(fenil-d5)-indan, dobiven u zahtjevu 11 konvertiran u farmaceutski prihvatljivu sol 4-((1R,3S)-6-kloro-3-(fenil-d5)-indan-1-il)-1(d3),2,2-trimetil-piperazina, postupak sadrži sljedeće korake
a) supstitucija nukleofila 3,5-dikloro-1-(fenil-d5)-indana s 1(d3),2,2-trimetil-piperazin bis-2,2,2-trifluoroacetatom ili spojem koji se naknadno može preoblikovati u 1(d3),2,2-trimetil-piperazin dio 4-((1R,3S)-6-kloro-3-(fenil-d5)-indan-1-il)-1(d3),2,2-trimetil-piperazina
b) precipitacija farmaceutski prihvatljive soli dodavanjem odgovarajuće kiseline.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261739095P | 2012-12-19 | 2012-12-19 | |
DKPA201200811 | 2012-12-19 | ||
EP13811511.8A EP2943460B1 (en) | 2012-12-19 | 2013-12-19 | 6-chloro-3-(phenyl-d5)-inden-1-one and use thereof |
PCT/EP2013/077314 WO2014096151A2 (en) | 2012-12-19 | 2013-12-19 | 6-chloro-3-(phenyl-d5)-inden-1-one and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20200385T1 true HRP20200385T1 (hr) | 2020-06-12 |
Family
ID=59295365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20200385TT HRP20200385T1 (hr) | 2012-12-19 | 2020-03-09 | 6-kloro-3-(fenil-d5)-inden-1-on i njegove uporabe |
Country Status (25)
Country | Link |
---|---|
US (1) | US9309165B2 (hr) |
EP (1) | EP2943460B1 (hr) |
JP (1) | JP6290921B2 (hr) |
KR (1) | KR102212096B1 (hr) |
CN (1) | CN104955796B (hr) |
AR (1) | AR094054A1 (hr) |
AU (1) | AU2013366693B2 (hr) |
BR (1) | BR112015014384A2 (hr) |
CA (1) | CA2893224C (hr) |
CL (1) | CL2015001720A1 (hr) |
CY (1) | CY1122715T1 (hr) |
DK (1) | DK2943460T3 (hr) |
HK (1) | HK1217688A1 (hr) |
HR (1) | HRP20200385T1 (hr) |
IL (1) | IL239097A (hr) |
LT (1) | LT2943460T (hr) |
MX (1) | MX365707B (hr) |
PL (1) | PL2943460T3 (hr) |
PT (1) | PT2943460T (hr) |
RS (1) | RS59982B1 (hr) |
RU (1) | RU2681221C2 (hr) |
SG (1) | SG11201504437SA (hr) |
SI (1) | SI2943460T1 (hr) |
WO (1) | WO2014096151A2 (hr) |
ZA (1) | ZA201504405B (hr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104628630B (zh) * | 2015-03-16 | 2017-01-18 | 哈尔滨工业大学 | 一种茚衍生物1‑吡啶基‑2‑溴茚及其合成方法 |
CN104892492A (zh) * | 2015-06-18 | 2015-09-09 | 哈尔滨工业大学 | 一种茚衍生物1-吡啶基-6-甲基茚及其合成方法 |
MA52183A (fr) * | 2018-04-06 | 2021-02-17 | H Lundbeck As | Procédé de préparation de 2,2-diméthylpipérazine |
CN112930341A (zh) * | 2018-10-29 | 2021-06-08 | H.隆德贝克有限公司 | 无定形的具有式(i)的化合物和无定形的具有式(i)的化合物的盐 |
WO2020114853A1 (en) | 2018-12-03 | 2020-06-11 | H. Lundbeck A/S | Prodrugs of 4-((1r,3s)-6-chloro-3-phenyl-2,3-dihydro-1h-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1/r,3s)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1h-inden-1-yl)-2,2-dimethy-1-(methyl-d3)piperazine |
KR102051783B1 (ko) * | 2019-09-02 | 2019-12-03 | 부산대학교 산학협력단 | 3,10-이치환 벤조풀벤 유도체의 신규 합성방법 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986003488A1 (en) * | 1984-12-04 | 1986-06-19 | Sandoz Ag | Indene analogs of mevalonolactone and derivatives thereof |
DE19538218A1 (de) * | 1995-10-13 | 1997-04-17 | Bayer Ag | Cyclopentan-1,3-dion-Derivate |
WO1999015524A1 (en) * | 1997-09-23 | 1999-04-01 | Fujisawa Pharmaceutical Co., Ltd. | Thiazole derivatives |
SE9904850D0 (sv) * | 1999-12-30 | 1999-12-30 | Pharmacia & Upjohn Ab | Novel process and intermediates |
BRPI0413595B8 (pt) * | 2003-08-18 | 2021-05-25 | H Lundbeck As | sal de malonato, composição farmacêutica, uso de um sal de malonato, e, método de fabricação de um composto |
RU2366654C2 (ru) * | 2004-06-08 | 2009-09-10 | ЭнЭсЭйБи, ФИЛИАЛ АФ НЕУРОСЕРЧ СВИДЕН АБ, СВЕРИЙЕ | Новые дизамещенные фенилпиперидины/пиперазины в качестве модуляторов допаминовой нейротрансмиссии |
TWI453198B (zh) | 2005-02-16 | 2014-09-21 | Lundbeck & Co As H | 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s)-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法 |
ES2396365T3 (es) * | 2005-07-29 | 2013-02-21 | Concert Pharmaceuticals Inc. | Nuevos derivados de benzo[D][1,3]-dioxol deuterados como inhibidores de la recaptación de serotonina |
WO2008086158A1 (en) * | 2007-01-04 | 2008-07-17 | Smithkline Beecham Corporation | Benzodihydroquinazoline as pi3 kinase inhibitors |
TW201102370A (en) | 2009-07-07 | 2011-01-16 | Lundbeck & Co As H | Manufacture of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl piperazine |
KR101149529B1 (ko) * | 2009-09-11 | 2012-05-25 | 한국화학연구원 | 인덴온 유도체 및 이를 포함하는 약학적 조성물 |
JP5941410B2 (ja) | 2010-11-09 | 2016-06-29 | 株式会社カネカ | ハロゲン化インデノン類及びそれを用いた光学活性インダノン類又は光学活性インダノール類の製造方法 |
JP2014501771A (ja) | 2011-01-07 | 2014-01-23 | ハー・ルンドベック・アクチエゼルスカベット | 4−((1r,3s)−6−クロロ−3−フェニル−インダン−1−イル)−1,2,2−トリメチル−ピペラジンと1−((1r,3s)−6−クロロ−3−フェニル−インダン,1−イル)−3,3−ジメチル−ピペラジンとを分割するための方法 |
JP5668177B2 (ja) * | 2011-06-20 | 2015-02-12 | ハー・ルンドベック・アクチエゼルスカベット | 統合失調症の治療のための重水素化1−ピペラジノ−3−フェニルインダン |
-
2013
- 2013-12-17 AR ARP130104787A patent/AR094054A1/es active IP Right Grant
- 2013-12-19 JP JP2015548555A patent/JP6290921B2/ja active Active
- 2013-12-19 DK DK13811511.8T patent/DK2943460T3/da active
- 2013-12-19 AU AU2013366693A patent/AU2013366693B2/en active Active
- 2013-12-19 CA CA2893224A patent/CA2893224C/en active Active
- 2013-12-19 RU RU2015123308A patent/RU2681221C2/ru active
- 2013-12-19 EP EP13811511.8A patent/EP2943460B1/en active Active
- 2013-12-19 SI SI201331680T patent/SI2943460T1/sl unknown
- 2013-12-19 RS RS20200220A patent/RS59982B1/sr unknown
- 2013-12-19 US US14/653,318 patent/US9309165B2/en active Active
- 2013-12-19 BR BR112015014384A patent/BR112015014384A2/pt not_active Application Discontinuation
- 2013-12-19 PL PL13811511T patent/PL2943460T3/pl unknown
- 2013-12-19 WO PCT/EP2013/077314 patent/WO2014096151A2/en active Application Filing
- 2013-12-19 MX MX2015007727A patent/MX365707B/es active IP Right Grant
- 2013-12-19 LT LTEP13811511.8T patent/LT2943460T/lt unknown
- 2013-12-19 KR KR1020157015940A patent/KR102212096B1/ko active IP Right Grant
- 2013-12-19 CN CN201380065995.3A patent/CN104955796B/zh active Active
- 2013-12-19 PT PT138115118T patent/PT2943460T/pt unknown
- 2013-12-19 SG SG11201504437SA patent/SG11201504437SA/en unknown
-
2015
- 2015-05-31 IL IL239097A patent/IL239097A/en active IP Right Grant
- 2015-06-18 ZA ZA2015/04405A patent/ZA201504405B/en unknown
- 2015-06-18 CL CL2015001720A patent/CL2015001720A1/es unknown
-
2016
- 2016-05-18 HK HK16105696.8A patent/HK1217688A1/zh unknown
-
2020
- 2020-03-05 CY CY20201100198T patent/CY1122715T1/el unknown
- 2020-03-09 HR HRP20200385TT patent/HRP20200385T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20200385T1 (hr) | 6-kloro-3-(fenil-d5)-inden-1-on i njegove uporabe | |
Lemos et al. | Progress in difluoroalkylation of organic substrates by visible light photoredox catalysis | |
Pan et al. | Recent advances in photoinduced trifluoromethylation and difluoroalkylation | |
Soengas et al. | Modern synthetic methods for the stereoselective construction of 1, 3-dienes | |
Dixon et al. | Scalable, divergent synthesis of meroterpenoids via “borono-sclareolide” | |
Sahli et al. | Selective carbon–carbon bond formation: terpenylations of amines involving hydrogen transfers | |
CN107001214A (zh) | 环状二酮化合物的制造方法 | |
Supranovich et al. | Generation of Alkyl Radicals from Thiols via Zinc Thiolates: Application for the Synthesis of gem‐Difluorostyrenes | |
CN105566319A (zh) | 一种(s,s)-2,8-二氮杂二环[4,3,0]壬烷的制备方法 | |
Alonso et al. | Synthesis of resveratrol, DMU-212 and analogues through a novel Wittig-type olefination promoted by nickel nanoparticles | |
CN103864665A (zh) | 醋酸巴多昔芬的制备方法 | |
CN103214328B (zh) | 一种α-溴代芳香酮类化合物的合成方法 | |
CN104313635A (zh) | α-羰基酮类化合物的电化学催化合成方法 | |
JP5680009B2 (ja) | 5−アセトキシ−(e3)−3−ペンテニル−メトキシメチルエーテルを用いた(e3)−3−アルケニルアセタートの製造方法 | |
CN105693598A (zh) | 一种铱催化氢化合成3-哌啶酮衍生物的方法 | |
TWI551573B (zh) | Preparation of adamantane | |
Liu et al. | Directed hydrozirconation of homopropargylic alcohols | |
Morales-Serna et al. | Heck Arylation of Styrenes Promoted by an Air-Stable Phosphinito Complex with Palladium (II); Synthesis of Resveratrol | |
Guo et al. | A ligand-free, powerful, and practical method for methoxylation of unactivated aryl bromides by use of the CuCl/HCOOMe/MeONa/MeOH system | |
WO2017121699A1 (de) | Verfahren zur herstellung von substituierten 2-aryl-ethanolen | |
CN114645288B (zh) | 一种反式烯烃类化合物的制备方法 | |
Dupau | Hydrogenation towards Synthetic Sandalwood Odorants in Fragrance Industry | |
CN102120718A (zh) | 一种芳基丙醛衍生物的制备方法 | |
Andreica et al. | The Use of Mercury Compounds in the Synthesis of Some Lepidoptera Insect Sex Pheromones with Monoenic Structure | |
CN105732382A (zh) | 用于制备4-烷基-3-甲烯基丁基羧酸酯的方法 |